Skip to main content

Transrectal Laser Focal Therapy of Prostate Cancer

  • Chapter
  • First Online:
Imaging and Focal Therapy of Early Prostate Cancer

Abstract

Laser focal therapy (LFT) is an evolving ablative technique for the treatment of prostate cancer. Also referred to as laser interstitial thermal therapy (LITT) or focal laser ablation (FLA), this intervention is based on heating of the prostate with an infrared laser to produce tissue destruction from coagulative necrosis. While earlier work focused on a transperineal approach, this has evolved to a less-invasive, transrectal approach delivered in the outpatient setting. This chapter examines the history, mechanism of action, and technique of transrectal magnetic resonance imaging (MRI)-guided LFT with real-time thermometry. We describe the equipment, procedure, and early safety and feasibility results of a series of patients in a clinical trial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Phase II Laser Focal Therapy of Prostate Cancer (LITT or FLA). NCT02243033. clinicaltrials.gov/ct2/show/NCT02243033. Accessed 14 Feb 2016.

    Google Scholar 

  2. Oto A, Sethi I, Karczmar G, McNichols R, Ivancevic MK, Stadler WM, et al. MR imaging-guided focal laser ablation for prostate cancer: phase I trial. Radiology. 2013;267(3):932–40.

    Article  PubMed  Google Scholar 

  3. Garcia-Medina O, Gorny K, McNichols R, Friese J, Misra S, Amrami K, et al. In vivo evaluation of a MR-guided 980 nm laser interstitial thermal therapy system for ablations in porcine liver. Lasers Surg Med. 2011;43(4):298–305.

    Article  PubMed  Google Scholar 

  4. Stafford RJ, Shetty A, Elliott AM, Klumpp SA, McNichols RJ, Gowda A, et al. Magnetic resonance guided, focal laser induced interstitial thermal therapy in a canine prostate model. J Urol. 2010;184(4):1514–20.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Neff T. First-ever targeted laser prostate surgery a success. UCH Insider. 2009;3(8). http://www3.uch.edu/uchinsider/laser%20prostate%20surgery.pdf

  6. MR-Guided Laser Ablation of Prostate Bed Recurrences. NCT01743638. https://clinicaltrials.gov/ct2/show/NCT01743638. Accessed 15 Sept 2016.

  7. MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer. NCT00448695. https://clinicaltrials.gov/ct2/show/NCT00448695. Accessed 15 Sept 2016.

  8. MR-Guided Laser Interstitial Thermal Therapy in Treating Patients with Prostate Cancer. NCT01792024. https://clinicaltrials.gov/ct2/show/NCT01792024. Accessed 15 Sept 2016.

  9. Raz O, Haider MA, Davidson SR, Lindner U, Hlasny E, Weersink R, et al. Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. Eur Urol. 2010;58(1):173–7.

    Article  PubMed  Google Scholar 

  10. Lindner U, Lawrentschuk N, Weersink RA, Davidson SR, Raz O, Hlasny E, et al. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. Eur Urol. 2010;57(6):1111–4.

    Article  PubMed  Google Scholar 

  11. Woodrum DA, Mynderse LA, Gorny KR, Amrami KK, McNichols RJ, Callstrom MR. 3.0 T MR-guided laser ablation of a prostate cancer recurrence in the postsurgical prostate bed. J Vasc Interv Radiol. 2011;22(7):929–34.

    Article  PubMed  Google Scholar 

  12. Wenger H, Yousuf A, Oto A, Eggener S. Laser ablation as focal therapy for prostate cancer. Curr Opin Urol. 2014;24(3):236–40.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Curry DJ, Gowda A, McNichols RJ, Wilfong AA. MR-guided stereotactic laser ablation of epileptogenic foci in children. Epilepsy Behav. 2012;24(4):408–14.

    Article  PubMed  Google Scholar 

  14. Carpentier A, Chauvet D, Reina V, Beccaria K, Leclerq D, McNichols RJ, et al. MR-guided laser-induced thermal therapy (LITT) for recurrent glioblastomas. Lasers Surg Med. 2012;44(5):361–8.

    Article  PubMed  Google Scholar 

  15. Beyersdorff D, Winkel A, Hamm B, Lenk S, Loening SA, Taupitz M. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology. 2005;234(2):576–81.

    Article  PubMed  Google Scholar 

  16. Schertz A. Advancements improve prostate exams. BizTimes. Aug 20, 2010.

    Google Scholar 

  17. Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, et al. Focal therapy: patients, interventions, and outcomes–a report from a consensus meeting. Eur Urol. 2015;67(4):771–7.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND/UCLA appropriateness method user’s manual. Santa Monica, CA: RAND Corporation; 2001 .http://www.rand.org/pubs/monograph_reports/MR1269.html

  19. van der Poel H, Klotz L, Andriole G, Azzouzi AR, Bjartell A, Cussenot O, et al. Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers. World J Urol. 2015;33(7):907–16.

    Article  PubMed  Google Scholar 

  20. Abd-Alazeez M, Ahmed HU, Arya M, Charman SC, Anastasiadis E, Freeman A, et al. The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level–can it rule out clinically significant prostate cancer? Urol Oncol. 2014;32(1):45.e17–22.

    Google Scholar 

  21. Fütterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. 2015;68(6):1045–53.

    Article  PubMed  Google Scholar 

  22. Shigemura K, Yamanaka N, Yamashita M. Can diffusion-weighted magnetic resonance imaging predict a high Gleason score of prostate cancer? Korean J Urol. 2013;54(4):234–8.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Nagarajan R, Margolis D, Raman S, Sheng K, King C, Reiter R, et al. Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer. Adv Urol. 2012;2012:374805.

    Article  PubMed  Google Scholar 

  24. deSouza NM, Riches SF, Vanas NJ, Morgan VA, Ashley SA, Fisher C, et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol. 2008;63(7):774–82.

    Article  CAS  PubMed  Google Scholar 

  25. Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, van de Hulsbergen Kaa CA, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology. 2011;259(2):453–61.

    Article  PubMed  Google Scholar 

  26. Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging – reporting and data system: 2015, Version 2. Eur Urol. 2016;69(1):16–40.

    Article  PubMed  Google Scholar 

  27. Medtronic Indications, Safety, and Warnings Visualase Thermal Therapy System. http://www.medtronic.com/for-healthcare-professionals/products-therapies/neurological/laser-ablation/visualase/indications-safety-warnings/index.htm. Accessed 5 Mar 2016.

  28. U.S. Food and Drug Administration MAUDE Adverse Event Report Database. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=5101035. Accessed 8 Mar 2016.

  29. Nash PA, Bruce JE, Indudhara R, Shinohara K. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J Urol. 1996;155(2):607–9.

    Article  CAS  PubMed  Google Scholar 

  30. Soloway MS, Obek C. Periprostatic local anesthesia before ultrasound guided prostate biopsy. J Urol. 2000163(1):172–3.

    Google Scholar 

  31. Le Nobin J, Orczyk C, Deng FM, Melamed J, Rusinek H, Taneja SS, et al. Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software. BJU Int. 2014;114(6b):E105–12.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Whinnery JR, Ausubel J, Langford HD; National Academy of Engineering. Lasers: invention to application. Washington, DC: National Academy Press; 1987.

    Google Scholar 

  33. Ishihara Y, Calderon A, Watanabe H, Okamoto K, Suzuki Y, Kuroda K, et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med. 1995;34(6):814–23.

    Article  CAS  PubMed  Google Scholar 

  34. Rieke V, Butts Pauly K. MR thermometry. J Magn Reson Imaging. 2008;27(2):376–90.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Henriques FC. Studies of thermal injury, V. The predictability and significance of thermally induced rate processes leading to irreversible epidermal injury. Arch Pathol. 1947;43:489–502.

    Google Scholar 

  36. Pearce JA. Comparative analysis of mathematical models of cell death and thermal damage processes. Int J Hyperthermia. 2013;29(4):262–80.

    Article  PubMed  Google Scholar 

  37. McNichols RJ, Gowda A, Kangasniemi M, Bankson JA, Price RE, Hazle JD. MR thermometry-based feedback control of laser interstitial thermal therapy at 980 nm. Lasers Surg Med. 2004;34(1):48–55.

    Article  PubMed  Google Scholar 

  38. Lee T, Mendhiratta N, Sperling D, Lepor H. Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience. Rev Urol. 2014;16(2):55–66.

    PubMed  PubMed Central  Google Scholar 

  39. Lepor H, Llukani E, Sperling D, Fütterer JJ. Complications, recovery, and early functional outcomes and oncologic control following in-bore focal laser ablation of prostate cancer. Eur Urol. 2015;68(6):924–6.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge the skill and expertise of our interventional radiologist, Stuart T. May, MD and our MRI technologist, Wes Jones, RT. We also acknowledge the early work of Roger J. McNichols, PhD, who saw the potential of light and harnessed it. Without him much of our work would have been impossible. We dedicate this chapter to him. BMG, JFF, and RJS.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John F. Feller M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Feller, J.F., Greenwood, B.M., Stafford, R.J. (2017). Transrectal Laser Focal Therapy of Prostate Cancer. In: Polascik, T. (eds) Imaging and Focal Therapy of Early Prostate Cancer. Current Clinical Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-49911-6_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-49911-6_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-49910-9

  • Online ISBN: 978-3-319-49911-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics